#34 – The New Scoop on Poop: Updates in the Management of C. difficile infections
Breakpoints19 Feb 2021

#34 – The New Scoop on Poop: Updates in the Management of C. difficile infections

Dr. Kevin Garey (@GareyKgarey), Dr. Kelly Reveles (@KellyReveles), Dr. Mandelin Cooper, and host Dr. Rachel Britt (@RachelBPharmD) discuss proposed updates of the IDSA-SHEA C. difficile guidelines, including: fidaxomicin over oral vancomycin as first-line therapy, the roles and logistical hurdles of fecal microbiota transplant, bezlotoxumab, and the pros and cons of prophylaxis.

Timestamps

1:16 - Panel introductions 3:19 - Fidaxomicin vs PO vancomycin for first occurrence 7:21 - Fidaxomicin cost effectiveness 11:26 - Factors to consider for health systems when considering switch to fidaxomicin 14:23 - Fidaxomicin vs PO vancomycin for recurrences 17:52 - Role of pulsed and tapered PO vancomycin 19:57 - Role of fecal microbiota transplant (FMT) 22:24 - Challenges of FMT and where pharmacy fits in 27:27 - Bezlotoxumab 31:54 - Feasibility issues with bezlotoxumab and strategies to address them 35:25 - CDI prophylaxis 40:28 - Stewardship's role in reducing C. difficile infections

References

Fidaxomicin Cost-effectiveness

  • Reveles KR, et al. Pharmacotherapy. 2017;37(12):1489-97.
  • Watt M, et al. Infection. 2016;44(5):599-606.
  • Cornely OA, et al. J Antimicrob Chemother. 2018;73(9):2529-39.
  • Rubio-Terres C, et al. Eur J Clin Microbiol Infect Dis. 2019;38(6):1105-11.

Bezlotoxumab

  • Wilcox MH, et al. N Engl J Med. 2017;376:305-17.
  • Oksi J, et al. Eur J Clin Microbiol Infect Dis. 2019;38(10):1947-52.
  • Hengel RL, et al. Open Forum Infect Dis. 2020;7(4):ofaa097.

Bezlotoxumab Cost-effectiveness

  • Salavert M, et al. Adv Ther. 2018;35(11):1920-34.
  • Prabhu VS, et al. Clin Infect Dis. 2018;66(3):355-62.

Primary prophylaxis

  • Pereiras MA, et al. Biol Blood Marrow Transplant. 2017; 23:S395.
  • Ganetsky A, et al. Clin Infect Dis. 2019;68(12):2003-2009.
  • Mullane KM, et al. Clin Infect Dis. 2019; 68(2):196–203.

Secondary prophylaxis

  • Carignan A, et al. Am J Gastroenterol. 2016;111:1834-1840.
  • Van Hise NW, et al. Clin Infect Dis. 2016;63:651-653.
  • Splinter et al. Ann Pharmacother. 2018;52:113-119.
  • Knight EM, et al. J Pharm Pract. 2019;:897190019825994.
  • Morrisette T, et al. Biol Blood Marrow Transplant. 2019;25(10):2091-2097.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(134)

#22 – Taking a “BITE” Out of Antibiotic Prescribing: The Need for Antimicrobial Stewardship in Dentistry

#22 – Taking a “BITE” Out of Antibiotic Prescribing: The Need for Antimicrobial Stewardship in Dentistry

Dr. Katie Suda (@sudamonas) and Dr. Erinne Kennedy join Dr. Zahra Escobar (@zkepharmd) of the Breakpoints team to discuss why dentists prescribe 1 in 10 of all antibiotics in the United States and how...

15 Mai 202037min

#21 – Frontline Allies: Emergency Medicine and Critical Care Insights into COVID19

#21 – Frontline Allies: Emergency Medicine and Critical Care Insights into COVID19

Dr. Jenny Koehl (@jlkoehl), Dr. Karen Berger (@karenccrx), and Dr. Karen Dohr join host Erin McCreary (@erinmccreary) to discuss taking care of patients with COVID-19 in the Emergency Department and I...

27 Apr 20201h 1min

#20 – What is Happening Right Now? COVID-19 Challenges and Silver Linings

#20 – What is Happening Right Now? COVID-19 Challenges and Silver Linings

Julie Ann Justo (@julie_justo), Jason Pogue (@jpogue1), and Erin McCreary (@erinmccreary) discuss critically evaluating COVID-19 literature, staying calm in the storm, strategies for team education an...

13 Apr 20201h 1min

#19 – Push and Pull: Combating Antibiotic Resistance from Discovery to Market Reform

#19 – Push and Pull: Combating Antibiotic Resistance from Discovery to Market Reform

Dr. Mike Dudley (@MikeMndudley), President and CEO of Qpex Biopharma, joins Dr. Erin McCreary (@erinmccreary) to discuss the thrills and failures of antibiotic discovery and development along with the...

21 Feb 20201h 24min

#18 – Waking the Sleeping Giant: Engaging Nurses in Antimicrobial Stewardship

#18 – Waking the Sleeping Giant: Engaging Nurses in Antimicrobial Stewardship

Dr. David Ha (@DHpharmd) interviews Dr. Rita Olans (@RitaOlans) and Dr. Elizabeth Monsees (@eamonsees) about the critical role nurses play in antimicrobial stewardship. They discuss how nursing practi...

17 Jan 202046min

#17 – See C. diff: A Discussion on Patient Advocacy

#17 – See C. diff: A Discussion on Patient Advocacy

Christian John Lillis, co-founder and Executive Director of the Peggy Lillis Foundation (@peggyfund), joins Erin McCreary (@erinmccreary) to share his mother’s story and discuss opportunities and chal...

20 Des 20191h 15min

#16 – 5 Ways Hospital Pharmacists Can Be Antibiotics Aware

#16 – 5 Ways Hospital Pharmacists Can Be Antibiotics Aware

Dr. Susan Davis (@IDPharmProf) and Dr. Jason Pogue (@jpogue1) celebrate Antibiotic Awareness Week by discussing the 5 Ways Hospital Pharmacists Can Be Antibiotics Aware, including: verify penicillin a...

20 Nov 201948min

#15 – CDC Core Elements of Hospital Antibiotic Stewardship Programs: 2019 Update

#15 – CDC Core Elements of Hospital Antibiotic Stewardship Programs: 2019 Update

Dr. Arjun Srinivasan and Dr. Melinda Neuhauser join host Dr. Erin McCreary (@erinmccreary) to discuss the updated Core Elements of Hospital Antibiotic Stewardship Programs from the Centers for Disease...

18 Nov 201953min

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
foreldreradet
rss-bisarr-historie
treningspodden
jakt-og-fiskepodden
rss-strid-de-norske-borgerkrigene
rss-kunsten-a-leve
mikkels-paskenotter
rss-sunn-okonomi
sinnsyn
hverdagspsyken
rss-kull
tomprat-med-gunnar-tjomlid
lederskap-nhhs-podkast-om-ledelse
fryktlos
gravid-uke-for-uke
hagespiren-podcast
rss-bak-luftfarten